These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 683716)

  • 1. [Antibodies to bradykinin, kallikrein and inflammation].
    Zaks AS; Bykova AA
    Patol Fiziol Eksp Ter; 1978; (3):66-7. PubMed ID: 683716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibodies to mediators of inflammation as its inhibitors and analyzers].
    Zaks AS; Bykova AA; Suslina ML
    Farmakol Toksikol; 1977; 40(2):190-3. PubMed ID: 852559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunochemical approach to studying the body's kallikrein-kinin system].
    Protsenko VA
    Patol Fiziol Eksp Ter; 1979; (5):73-6. PubMed ID: 388326
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the arterial pressure and activity of kallikrein-kinin system components during immunization of rabbits with erythrocyte bradykinin conjugate].
    Petriĭ OP; Karpitskiĭ VV; Komissarova NV; Gomazkov OA
    Dokl Akad Nauk SSSR; 1988; 300(5):1256-60. PubMed ID: 3168751
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immune mechanism of regulating the balance of chemical compounds of endogenous origin].
    Zaks AS; Bykova AA
    Fiziol Zh SSSR Im I M Sechenova; 1977 Sep; 63(9):1319-25. PubMed ID: 72006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of bradykinin and kallikrein on plasma proteins in the inflammatory process in rabbits].
    Lichota E; Mietkiewski E; Danieyko-Osman M; Legiecka B
    Ann Acad Med Stetin; 1981; 27():343-51. PubMed ID: 6921012
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of the ureteral contractions induced by rat urine with kallikrein antibodies.
    Marin-Grez M; Speck G; Hilgenfeldt U; Schaechtelin G
    Experientia; 1983 Apr; 39(4):360-2. PubMed ID: 6550534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody that recognizes total human urinary kallikrein: radioimmunological determination of inactive kallikrein.
    Oza NB; Lieberthal W; Bernard DB; Levinsky NG
    J Immunol; 1981 Jun; 126(6):2361-4. PubMed ID: 6908911
    [No Abstract]   [Full Text] [Related]  

  • 9. Production and characterization of antipeptide kallikrein 4 antibodies. Use of computer modeling to design peptides specific to Kallikrein 4.
    Harvey TJ; Dong Y; Bui L; Jarrott R; Walsh T; Clements JA
    Methods Mol Med; 2003; 81():241-54. PubMed ID: 12725124
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of iodinated kallikrein on the rat uterus.
    Feitosa MH; Pesquero JL; Oliveira GM; Beraldo WT; Heneine IF
    Agents Actions Suppl; 1992; 36():265-70. PubMed ID: 1609650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung.
    Ercan ZS; Bor NM; Torunoğlu M; Türker RK
    Arzneimittelforschung; 1982; 32(1):30-1. PubMed ID: 6174131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The radioimmunoassay of bradykinin in the measurement of kallikrein in urine.
    Macfarlane NA; Adetuyibi A; Mills IH
    J Endocrinol; 1973 Jul; 58(1):xxv. PubMed ID: 4722552
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma exudation by activated plasma kallikrein after intraperitoneal injection of lambda-carrageenin or endotoxin in rats.
    Sugimoto K; Shindo M; Owada T; Majima M; Katori M
    Agents Actions Suppl; 1992; 38 ( Pt 3)():376-84. PubMed ID: 1462870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.
    Sancho-Bru P; Bataller R; Fernandez-Varo G; Moreno M; Ramalho LN; Colmenero J; Marí M; Clària J; Jiménez W; Arroyo V; Brenner DA; Ginès P
    Gastroenterology; 2007 Dec; 133(6):2019-28. PubMed ID: 18054572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intensity of kininergic reactions of the cardiovascular system in different activities of the plasma kallikrein-kinin system].
    Kiselev VI; Lebedev NM
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):386-90. PubMed ID: 6552214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New data on kallikrein in rabbit serum].
    Paskhina TS; Zykova VP
    Dokl Akad Nauk SSSR; 1967 Apr; 173(6):1451-4. PubMed ID: 5623167
    [No Abstract]   [Full Text] [Related]  

  • 17. Bradykinin antibodies: new developments.
    Hilgenfeldt U; Linke R; König W
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S17-9. PubMed ID: 1697355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of bradykinin generating and degrading systems in the vascular permeability response induced with kaolin in rats.
    Kumakura S; Tsurufuji S; Kurooka S; Sunahara N
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1067-73. PubMed ID: 3320343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury.
    Chiang WC; Chien CT; Lin WW; Lin SL; Chen YM; Lai CF; Wu KD; Chao J; Tsai TJ
    Free Radic Biol Med; 2006 Oct; 41(8):1304-14. PubMed ID: 17015177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.